3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Esophageal Neoplasms
3
Esophageal Squamous Cell Carcinoma
2
Squamous Cell Carcinoma of Head and Neck
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Endometrial Neoplasms
1
Interventions
Cisplatin
24
Paclitaxel
21
pembrolizumab
15
Radiotherapy
12
Fluorouracil
12
Carboplatin
12
Drug Therapy
11
tislelizumab
10
toripalimab
9
Irinotecan
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Radiation
5
Neoadjuvant Therapy
5
Leucovorin
5
lenvatinib
4
camrelizumab
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Docetaxel
4
130-nm albumin-bound paclitaxel
4
apatinib
3
Taxes
3
Itraconazole
3
Injections
3
Albumin-Bound Paclitaxel
3
spartalizumab
2
sintilimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
TP protocol
×
1 year
×
Clear all
NCT06143748
2026-04-23
EC-CRT-006
Sun Yat-sen University
Phase 2
Active not recruiting
46 enrolled
NCT06601309
2025-09-15
ESCC
Fujian Medical University Union Hospital
Phase 2
Recruiting
90 enrolled